To develop each drug module, we carefully curate the best clinically-validated PK/PD models. Our Continuous Learning approach ensures that every model stays up-to-date and relevant while improving its predictive power for an increasingly complex patient set.
InsightRX models are specific to a drug, patient population, and disease indication to provide the best predictive ability.
Models are checked for quality, completeness, and numerical stability.
The InsightRX computational API undergoes rigorous testing for quality assurance.
Model predictive checks
Prior to deploying a drug module, all models are checked for predictive performance utilizing your institution's data to ensure precision.
InsightRX modules are continually re-optimized with data collected at scale over time.
Re-optimized modules provide a more precise understanding of unique patient subgroups, predictive covariates, drug-drug interactions, and pharmacogenomic effects